Cite

HARVARD Citation

    Lee, S. et al. (2016). Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study. Digestive and liver disease. 48 (3), pp. 344-. [Online]. 
  
Back to record